RT Journal Article
T1 Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
A1 Pérez Ríos, Mónica
A1 López Medina, Diana Carolina
A1 Guerra Tort, Carla
A1 Rey Brandariz, Julia
A1 Varela Lema, María Leonor
A1 Santiago Pérez, María Isolina
A1 Candal Pedreira, Cristina
A1 Montes Martínez, Agustín
A1 López Medina, María José
A1 Dalmau, Regina
A1 Provencio Pulla, Mariano
A1 Fernández, Esteve
A1 Blanco, Ana
A1 Ruano Raviña, Alberto
K1 Second hand tobacco smoke
K1 Mortality
K1 Lung cancer
K1 Ischemic heart disease
K1 Chronic obstructive pulmonary disease
K1 Cerebrovascular disease
AB Introduction and objectives: Exposure to environmental tobacco smoke (ETS) is associated with increased mortality and morbidity. The objective of this study was to estimate the impact of ETS exposure in Spain on mortality in 2020 in the population aged 35 years and over. Methods: A method of estimating attributable mortality (AM) based on the prevalence of ETS exposure was applied. Prevalence data were obtained from a representative study conducted in Spain and the relative risks were derived from a meta-analysis. AM point estimates are presented along with 95% confidence intervals (95% CI), calculated using a bootstrap naive procedure. AM, both overall and by smoking habit, was estimated for each combination of sex, age group, and cause of death (lung cancer and ischemic heart disease). A sensitivity analysis was performed.Results: A total of 747 (95% CI 676–825) deaths were attributable to ETS exposure, of which 279 (95% CI 256–306) were caused by lung cancer, and 468 (95% CI 417–523) by ischemic heart disease. Three quarters (75.1%) of AM occurred in men and 60.9% in non-smokers. When chronic obstructive pulmonary disease and cerebrovascular disease are included, the burden of AM is estimated at 2242 deaths.Conclusions: ETS exposure is associated with 1.5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. These data underline the need for health authorities to focus on reducing exposure to ETS in all settings and environments
PB Elsevier
YR 2023
FD 2023
LK http://hdl.handle.net/10347/30608
UL http://hdl.handle.net/10347/30608
LA eng
NO Archivos de Bronconeumología 59 (2023) 305–310
NO Instituto de Salud Carlos III (ISCIII), reference: PI22/00727, co-funded by the European Union
DS Minerva
RD 24 abr 2026